Your browser doesn't support javascript.
loading
Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron.
Martínez-González, Brenda; Vázquez-Sirvent, Lucía; Soria, María E; Mínguez, Pablo; Salar-Vidal, Llanos; García-Crespo, Carlos; Gallego, Isabel; de Ávila, Ana I; Llorens, Carlos; Soriano, Beatriz; Ramos-Ruiz, Ricardo; Esteban, Jaime; Fernandez-Roblas, Ricardo; Gadea, Ignacio; Ayuso, Carmen; Ruíz-Hornillos, Javier; Pérez-Jorge, Concepción; Domingo, Esteban; Perales, Celia.
Affiliation
  • Martínez-González B; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Vázquez-Sirvent L; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Soria ME; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Mínguez P; Centro de Biología Molecular "Severo Ochoa" (CBMSO), Consejo Superior de Investigaciones Científicas (CSIC-UAM), Campus de Cantoblanco, Madrid, Spain.
  • Salar-Vidal L; Department of Genetics and Genomics, IIS-FJD, UAM, Madrid, Spain.
  • García-Crespo C; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Gallego I; Bioinformatics Unit, IIS-FJD, UAM, Madrid, Spain.
  • de Ávila AI; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Llorens C; Centro de Biología Molecular "Severo Ochoa" (CBMSO), Consejo Superior de Investigaciones Científicas (CSIC-UAM), Campus de Cantoblanco, Madrid, Spain.
  • Soriano B; Centro de Biología Molecular "Severo Ochoa" (CBMSO), Consejo Superior de Investigaciones Científicas (CSIC-UAM), Campus de Cantoblanco, Madrid, Spain.
  • Ramos-Ruiz R; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
  • Esteban J; Centro de Biología Molecular "Severo Ochoa" (CBMSO), Consejo Superior de Investigaciones Científicas (CSIC-UAM), Campus de Cantoblanco, Madrid, Spain.
  • Fernandez-Roblas R; Biotechvana, "Scientific Park," Universidad de Valencia, Valencia, Spain.
  • Gadea I; Biotechvana, "Scientific Park," Universidad de Valencia, Valencia, Spain.
  • Ayuso C; Unidad de Genómica, "Scientific Park of Madrid," Campus de Cantoblanco, Madrid, Spain.
  • Ruíz-Hornillos J; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Pérez-Jorge C; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Domingo E; Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Perales C; Department of Genetics and Genomics, IIS-FJD, UAM, Madrid, Spain.
J Clin Invest ; 132(9)2022 05 02.
Article in En | MEDLINE | ID: mdl-35259127
Replication of SARS-CoV-2 in the human population is defined by distributions of mutants that are present at different frequencies within the infected host and can be detected by ultra-deep sequencing techniques. In this study, we examined the SARS-CoV-2 mutant spectra of amplicons from the spike-coding (S-coding) region of 5 nasopharyngeal isolates derived from patients with vaccine breakthrough. Interestingly, all patients became infected with the Alpha variant, but amino acid substitutions that correspond to the Delta Plus, Iota, and Omicron variants were present in the mutant spectra of the resident virus. Deep sequencing analysis of SARS-CoV-2 from patients with vaccine breakthrough revealed a rich reservoir of mutant types and may also identify tolerated substitutions that can be represented in epidemiologically dominant variants.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Affiliation country: Country of publication: